|
Real-time Estimate
Tradegate
14:15:11 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 37.30 EUR | +0.81% |
|
-1.60% | -9.80% |
| 09:53am | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 09-18 | Sanofi's Rabies Vaccine VaxRabeo Recommended for EU Approval | MT |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,194 | 112,665 | 112,549 | 116,968 | 100,655 | 88,717 | - | - |
| Change | - | 1.32% | -0.1% | 3.93% | -13.95% | -11.86% | - | - |
| Enterprise Value (EV) 1 | 121,177 | 119,102 | 120,342 | 125,740 | 111,663 | 100,180 | 97,053 | 93,606 |
| Change | - | -1.71% | 1.04% | 4.49% | -11.2% | -10.28% | -3.12% | -3.55% |
| P/E | 17.8x | 16.7x | 20.8x | 20.4x | 12.9x | 11.8x | 10.3x | 8.87x |
| PBR | 1.62x | 1.5x | 1.52x | 1.51x | 1.41x | 1.2x | 1.13x | 1.07x |
| PEG | - | 2.07x | -1.1x | 3.14x | 0.3x | -6.25x | 0.7x | 0.6x |
| Capitalization / Revenue | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 1.86x | 1.75x | 1.67x |
| EV / Revenue | 3.21x | 2.77x | 2.79x | 3.06x | 2.56x | 2.1x | 1.92x | 1.76x |
| EV / EBITDA | 9.95x | 8.14x | 8.44x | 9.76x | 8.22x | 6.8x | 6.19x | 5.51x |
| EV / EBIT | 11.3x | 9.13x | 9.5x | 11.1x | 9.19x | 7.53x | 6.93x | 6.18x |
| EV / FCF | 15x | 14x | 14.2x | 21.1x | 13.8x | 12.1x | 10.8x | 9.31x |
| FCF Yield | 6.68% | 7.12% | 7.04% | 4.74% | 7.24% | 8.29% | 9.28% | 10.7% |
| Dividend per Share 2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.254 | 4.496 | 4.795 |
| Rate of return | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 5.74% | 6.07% | 6.47% |
| EPS 2 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.279 | 7.206 | 8.348 |
| Distribution rate | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 67.7% | 62.4% | 57.4% |
| Net sales 1 | 37,761 | 42,997 | 43,070 | 41,081 | 43,626 | 47,648 | 50,644 | 53,167 |
| EBITDA 1 | 12,183 | 14,627 | 14,259 | 12,889 | 13,583 | 14,728 | 15,673 | 16,990 |
| EBIT 1 | 10,714 | 13,040 | 12,670 | 11,343 | 12,149 | 13,312 | 13,999 | 15,142 |
| Net income 1 | 6,223 | 6,720 | 5,400 | 5,744 | 7,813 | 7,479 | 8,886 | 10,309 |
| Net Debt 1 | 9,983 | 6,437 | 7,793 | 8,772 | 11,008 | 11,463 | 8,336 | 4,889 |
| Reference price 2 | 88.58 | 89.84 | 89.76 | 93.74 | 82.72 | 74.05 | 74.05 | 74.05 |
| Nbr of stocks (in thousands) | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,216,810 | 1,198,069 | - | - |
| Announcement Date | 2/4/22 | 2/3/23 | 2/1/24 | 1/30/25 | 1/29/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 32.78x | 11.92x | 24.16x | 0.6% | 1,028B | |
| 30.03x | 6.68x | 18.7x | 1.99% | 651B | |
| 33.38x | 7.81x | 16.15x | 2.6% | 466B | |
| 19.33x | 4.72x | 11.71x | 2.81% | 346B | |
| 19.72x | 5.16x | 12.79x | 3.11% | 266B | |
| 21.26x | 4.42x | 12.58x | 1.99% | 259B | |
| 24.43x | 6.42x | 11.43x | 2.62% | 208B | |
| 12.52x | 4.56x | 9.46x | 4.01% | 191B | |
| -45.4x | 6.61x | 25.81x | 2.19% | 186B | |
| Average | 16.45x | 6.48x | 15.87x | 2.44% | 400.19B | |
| Weighted average by Cap. | 23.68x | 7.73x | 17.83x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
